Cargando…
Editorial to “Atrial fibrillation and the risk of 30‐day incident thromboembolic events and mortality in adults ≥50 years with COVID‐19”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753464/ https://www.ncbi.nlm.nih.gov/pubmed/33362884 http://dx.doi.org/10.1002/joa3.12477 |
| _version_ | 1783626048094601216 |
|---|---|
| author | Hsieh, Yu‐Cheng |
| author_facet | Hsieh, Yu‐Cheng |
| author_sort | Hsieh, Yu‐Cheng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7753464 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77534642020-12-22 Editorial to “Atrial fibrillation and the risk of 30‐day incident thromboembolic events and mortality in adults ≥50 years with COVID‐19” Hsieh, Yu‐Cheng J Arrhythm Editorial John Wiley and Sons Inc. 2020-12-03 /pmc/articles/PMC7753464/ /pubmed/33362884 http://dx.doi.org/10.1002/joa3.12477 Text en © 2020 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Heart Rhythm Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Editorial Hsieh, Yu‐Cheng Editorial to “Atrial fibrillation and the risk of 30‐day incident thromboembolic events and mortality in adults ≥50 years with COVID‐19” |
| title | Editorial to “Atrial fibrillation and the risk of 30‐day incident thromboembolic events and mortality in adults ≥50 years with COVID‐19” |
| title_full | Editorial to “Atrial fibrillation and the risk of 30‐day incident thromboembolic events and mortality in adults ≥50 years with COVID‐19” |
| title_fullStr | Editorial to “Atrial fibrillation and the risk of 30‐day incident thromboembolic events and mortality in adults ≥50 years with COVID‐19” |
| title_full_unstemmed | Editorial to “Atrial fibrillation and the risk of 30‐day incident thromboembolic events and mortality in adults ≥50 years with COVID‐19” |
| title_short | Editorial to “Atrial fibrillation and the risk of 30‐day incident thromboembolic events and mortality in adults ≥50 years with COVID‐19” |
| title_sort | editorial to “atrial fibrillation and the risk of 30‐day incident thromboembolic events and mortality in adults ≥50 years with covid‐19” |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753464/ https://www.ncbi.nlm.nih.gov/pubmed/33362884 http://dx.doi.org/10.1002/joa3.12477 |
| work_keys_str_mv | AT hsiehyucheng editorialtoatrialfibrillationandtheriskof30dayincidentthromboemboliceventsandmortalityinadults50yearswithcovid19 |